A Study of TAK-755 in Adults With Acute Ischemic Stroke

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 222 participants.

Also called NCT07392450

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 222 participants (planned count) (from the registry)
Sponsor
  • Takeda Registry lists this organization as the lead sponsor
Registry
  • NCT NCT07392450
  • jRCT jRCT2071260013
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Belgium, Brazil, China, France, Germany, Greece, India, Japan, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07392450. Randomized; quadruple masking; primary purpose treatment. Start 2026-05-17 (actual); primary completion 2027-12-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of TAK-755 in Adults With Acute Ischemic Stroke
Condition
Acute Ischemic Stroke
Intervention (Biological)
TAK-755
Intervention (Other)
Placebo
Lead sponsor
Takeda (class: industry)

Record details

Record id
cardio:ct-nct07392450
Content hash
8face60808c6d69db47b0e5b683cb24bcedb6d909d85d636493ed422580d7a39